National Academies touts nuclear medicine's revival
After a year of hearings and deliberations, the National Academies of Science has recommended that the U.S. government recommit financially to the advancement of nuclear medicine science.
After a year of hearings and deliberations, the National Academies of Science has recommended that the U.S. government recommit financially to the advancement of nuclear medicine science.
An NAS-convened committee linked many of nuclear medicine's lingering R&D problems to deteriorating infrastructure and loss of federal research dollars. In 2006, for instance, the Department of Energy cut funding to the Medical Applications and Science program by 85%. Lack of student interest in basic science in the U.S. is so severe that the committee also recommended federally funded advanced training programs outside the nation's borders.
"If we are serious about personalized medicine, then the vehicle to [it] will be through basic research in nuclear medicine," said committee chair Dr. Hedvig Hricak, director of radiology at Memorial Sloan-Kettering Cancer Center.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
